However, ELK1 is expressed in the clinical spectrum of prostate tumors (44), and in PCa cells the activation of AR target growth genes through ELK1 was constitutive and did not entail hyper-phosphorylation or activation of immediate early genes (31). The gene discussed is ELK1; the disease is prostate neoplasm.